Kerry M. Clem - 03 Sep 2022 Form 4 Insider Report for ACORDA THERAPEUTICS INC

Role
Chief Commercial Officer
Signature
/s/ Kerry M. Clem
Issuer symbol
N/A
Transactions as of
03 Sep 2022
Net transactions value
-$601
Form type
4
Filing time
07 Sep 2022, 07:59:16 UTC
Previous filing
20 Sep 2021
Next filing
04 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACOR Common Stock Tax liability $601 -1,511 -13% $0.3980 10,083 03 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the number of shares of the issuers Common Stock that were withheld to cover tax liability in connection with vesting and settlement of restricted stock units reported on a prior Form 4.